Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
Ebiomedicine
|
June 21, 2016
Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View
Eric Pasmant, Dominique Vidaud
Oncoscience
|
February 25, 2016
RAS MAPK inhibitors deregulation in leukemia
Eric Pasmant, Dominique Vidaud, Paola Ballerini
Journal of Medical Genetics
|
August 15, 2012
Neurofibromatosis type 1: from genotype to phenotype
Eric Pasmant, Michel Vidaud, Dominique Vidaud, et al.
Journal of Neuro-Oncology
|
August 6, 2010
Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors
Eric Pasmant, Dominique Vidaud, Marcus Harrison, et al.
Medecine Sciences : M/S
|
November 9, 2005
[Mutation mechanisms and their consequences]
Nadine Hanna, Béatrice Parfait, Dominique Vidaud, et al.
Annales De Biologie Clinique
|
December 2, 2015
[Interest of Droplet digital PCR in non-invasive prenatal testing]
Lucie Orhant, Aurélie Vasson, France Leturcq, et al.
Journal of Neuro-Oncology
|
June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumors
Eric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S
|
September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]
Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
Clinical Dysmorphology
|
December 5, 2012
Sporadic NF1 mutation associated with a de-novo 20q11.3 deletion explains the association of unusual facies, Moyamoya vasculopathy, and developmental delay, reported by Bertoli et al. in 2009
Claudia Santoro, Valérie Malan, Marta Bertoli, et al.
American Journal of Medical Genetics. Part A
|
August 1, 2012
Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family
Eric Pasmant, Jeanne Amiel, Diana Rodriguez, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
Ebiomedicine
|
June 21, 2016
Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View
Eric Pasmant, Dominique Vidaud
Oncoscience
|
February 25, 2016
RAS MAPK inhibitors deregulation in leukemia
Eric Pasmant, Dominique Vidaud, Paola Ballerini
Journal of Medical Genetics
|
August 15, 2012
Neurofibromatosis type 1: from genotype to phenotype
Eric Pasmant, Michel Vidaud, Dominique Vidaud, et al.
Journal of Neuro-Oncology
|
August 6, 2010
Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors
Eric Pasmant, Dominique Vidaud, Marcus Harrison, et al.
Medecine Sciences : M/S
|
November 9, 2005
[Mutation mechanisms and their consequences]
Nadine Hanna, Béatrice Parfait, Dominique Vidaud, et al.
Annales De Biologie Clinique
|
December 2, 2015
[Interest of Droplet digital PCR in non-invasive prenatal testing]
Lucie Orhant, Aurélie Vasson, France Leturcq, et al.
Journal of Neuro-Oncology
|
June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumors
Eric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S
|
September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]
Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
Clinical Dysmorphology
|
December 5, 2012
Sporadic NF1 mutation associated with a de-novo 20q11.3 deletion explains the association of unusual facies, Moyamoya vasculopathy, and developmental delay, reported by Bertoli et al. in 2009
Claudia Santoro, Valérie Malan, Marta Bertoli, et al.
American Journal of Medical Genetics. Part A
|
August 1, 2012
Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family
Eric Pasmant, Jeanne Amiel, Diana Rodriguez, et al.
Page
of 9